We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

While a federal judge squashed earlier plans for a 340B rebate pilot program, HHS appears poised to relaunch its attempts to transform the drug pricing program. Less than two weeks after the federal ...

A little over a month after a federal circuit court blocked the Health Resources and Services Administration’s (HRSA) scheduled implementation of its 340B Rebate Model Pilot Program largely due to ...

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing ...

On February 20, 2026, the Supreme Court held that the International Emergency Economic Powers Act “does not authorize the President to impose tariffs.” A key issue to watch is which of the tariffs ...

That has left us in both a financially strong position with $184 million of ARR, continuing with a greater than 100% NRR. Long-term relationships with our customers on average, 5 years with some of ...

THMA announces its 2026 Cardiovascular and Oncology Executive Convenings, bringing together C-suite leaders from major health systems and life sciences companies to address supply-chain disruption, ...

TrumpRX and DTC sales may expand prescription drug access, but they will not solve the affordability crisis by themselves.

Voluntary MFN commitments by 16 manufacturers reportedly cover ~70% of Medicare drug spending, potentially obviating ...

The Health Resources and Services Administration has extended the comment period on its 340B rebate model proposal from 30 days to 60 days after the American Hospital Association and other ...

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

A new report paints a stark picture of how a subset of large healthcare providers is drawing the lion’s share of 340B savings within a single state. The controversial drug discount program has been ...